Monday, February 23, 2009 7:38:36 PM
I will help, seeing as Dew ignored your question. I also think it is instructive, as safety counts for so much when there is competition in the therapy space, and IDIX has an atrocious record of concealing safety issues (e.g. HCV candidate too)
It is indeed true concerning the past Barraclude comparisons –
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=16357377
- and there was disbelief even when IDIX issued cautious forecasts -
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=16670487
Hidden from the read-me-first, suppressed for years on iHub in general, here is the central issue - they claimed the lower price was a "marketing tactic" - this is where I questioned that there must be something wrong -
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21343675
- soon there was a relevation on the board, like no-one knew before, that there WAS a big problem:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21392641
So, I wouldnt touch IDIX with a 10-foot pole - but I do like SPPI these days......very interesting.....
"....on the biotech battle-field, you need some élan...."
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
